Healthcare provider profile · identity verified

Philma Balite Opinaldo, MD

Allopathic & Osteopathic Physicians|Internal Medicine · POPLAR BLUFF, MO · NPI 1023128840

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Philma Balite Opinaldo, MD received $56.55 in general payments during 2025 across 3 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 337 claims for Jardiance by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$56.55

3 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$56.55	100.0%	3	2025

What were the payments for?

Payment categories

Category	Amount	Records
Education	$56.55	3

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$56.55	3	2025
Source payment records 2025-03-12 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source 2025-03-28 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source 2025-03-28 · Boehringer Ingelheim Pharmaceuticals, Inc. · $18.85 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	337	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	337	50

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Montelukast Sodium	Montelukast Sodium	1025	179
Gabapentin	Gabapentin	785	134
Levothyroxine Sodium	Levothyroxine Sodium	732	124
Fluticasone Propionate	Fluticasone Propionate	653	165
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	642	82
Atorvastatin Calcium	Atorvastatin Calcium	609	118
Omeprazole	Omeprazole	577	133
Pantoprazole Sodium	Pantoprazole Sodium	500	80
Albuterol Sulfate Hfa	Albuterol Sulfate	465	106
Famotidine	Famotidine	449	84
Metoprolol Succinate	Metoprolol Succinate	426	78
Furosemide	Furosemide	424	85
Duloxetine Hcl	Duloxetine Hcl	413	48
Topiramate	Topiramate	412	62
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	391	54
Tramadol Hcl	Tramadol Hcl	375	65
Losartan Potassium	Losartan Potassium	370	65
Lisinopril	Lisinopril	363	77
Jardiance	Empagliflozin	337	50
Potassium Chloride	Potassium Chloride	321	55
Rosuvastatin Calcium	Rosuvastatin Calcium	306	68
Pregabalin	Pregabalin	292	39
Amlodipine Besylate	Amlodipine Besylate	289	60
Metformin Hcl Er	Metformin Hcl	285	50
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	278	43
Tizanidine Hcl	Tizanidine Hcl	253	44
Buspirone Hcl	Buspirone Hcl	250	38
Pravastatin Sodium	Pravastatin Sodium	250	49
Meloxicam	Meloxicam	237	59
Ventolin Hfa	Albuterol Sulfate	218	43
Metoprolol Tartrate	Metoprolol Tartrate	208	38
Clopidogrel	Clopidogrel Bisulfate	207	28
Ropinirole Hcl	Ropinirole Hcl	207	29
Escitalopram Oxalate	Escitalopram Oxalate	199	40
Trazodone Hcl	Trazodone Hcl	195	33
Tamsulosin Hcl	Tamsulosin Hcl	194	34
Linzess	Linaclotide	193	26
Alprazolam	Alprazolam	191	27
Ozempic	Semaglutide	173	26
Allopurinol	Allopurinol	172	31
Venlafaxine Hcl Er	Venlafaxine Hcl	167	25
Donepezil Hcl	Donepezil Hcl	162	32
Celecoxib	Celecoxib	152	26
Farxiga	Dapagliflozin Propanediol	152	30
Trulicity	Dulaglutide	150	19
Vascepa	Icosapent Ethyl	135	22
Hydrochlorothiazide	Hydrochlorothiazide	134	31
Baclofen	Baclofen	128	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	127	16
Metformin Hcl	Metformin Hcl	122	22
Carvedilol	Carvedilol	118	22
Eliquis	Apixaban	115	16
Diclofenac Sodium	Diclofenac Sodium	113	41
Methocarbamol	Methocarbamol	113	24
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	112	22
Fenofibrate	Fenofibrate Nanocrystallized	112	17
Aripiprazole	Aripiprazole	110	16
Citalopram Hbr	Citalopram Hydrobromide	108	21
Glimepiride	Glimepiride	106	23
Ezetimibe	Ezetimibe	101	32
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	96	18
Hydroxyzine Pamoate	Hydroxyzine Pamoate	90	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	90	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	18
Tresiba Flextouch U-200	Insulin Degludec	87	14
Dexlansoprazole Dr	Dexlansoprazole	86	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	83	11
Promethazine Hcl	Promethazine Hcl	83	18
Ibuprofen	Ibuprofen	81	18
Shingrix	Varicella-Zoster Ge/As01b/Pf	81	58
Estradiol	Estradiol	80	11
Methylprednisolone	Methylprednisolone	80	59
Myrbetriq	Mirabegron	78	16
Symbicort	Budesonide/Formoterol Fumarate	76	17
Hydralazine Hcl	Hydralazine Hcl	73	12
Sertraline Hcl	Sertraline Hcl	73	17
Humalog Kwikpen U-100	Insulin Lispro	72	11
Ondansetron Hcl	Ondansetron Hcl	72	16
Azithromycin	Azithromycin	71	51
M-Natal Plus	Pnv,calcium 72/Iron/Folic Acid	69	11
Cefdinir	Cefdinir	67	47
Bupropion Hcl	Bupropion Hcl	66	16
Quetiapine Fumarate	Quetiapine Fumarate	66	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	65	40
Zolpidem Tartrate	Zolpidem Tartrate	64	suppressed
Clonidine Hcl	Clonidine Hcl	63	suppressed
Simvastatin	Simvastatin	63	13
Fluconazole	Fluconazole	62	33
Metoclopramide Hcl	Metoclopramide Hcl	62	suppressed
Amoxicillin	Amoxicillin	58	42
Alendronate Sodium	Alendronate Sodium	57	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	57	48
Lorazepam	Lorazepam	57	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	55	11
Roflumilast	Roflumilast	55	suppressed
Azelastine Hcl	Azelastine Hcl	54	18
Spiriva Respimat	Tiotropium Bromide	54	suppressed
Xarelto	Rivaroxaban	53	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	41
Diazepam	Diazepam	48	suppressed
Januvia	Sitagliptin Phosphate	48	13
Clonazepam	Clonazepam	47	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	46	suppressed
Lovastatin	Lovastatin	46	suppressed
Mupirocin	Mupirocin	46	24
Spironolactone	Spironolactone	46	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	15
Arexvy	Rsvpref3 Antigen/As01e/Pf	44	44
Rexulti	Brexpiprazole	44	suppressed
Memantine Hcl	Memantine Hcl	41	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	40	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	39	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	39	suppressed
Meclizine Hcl	Meclizine Hcl	39	13
Bumetanide	Bumetanide	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	suppressed
Ketoconazole	Ketoconazole	37	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	suppressed
Naproxen	Naproxen	35	suppressed
Doxepin Hcl	Doxepin Hcl	34	suppressed
Rybelsus	Semaglutide	34	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	33	suppressed
Mometasone Furoate	Mometasone Furoate	33	suppressed
Nitroglycerin	Nitroglycerin	32	12
Ondansetron Odt	Ondansetron	32	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Synthroid	Levothyroxine Sodium	32	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	31	suppressed
Nystatin	Nystatin	31	17
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Risperidone	Risperidone	31	suppressed
Humalog Kwikpen U-200	Insulin Lispro	30	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	29	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Midodrine Hcl	Midodrine Hcl	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	27	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Testosterone Cypionate	Testosterone Cypionate	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Verapamil Er	Verapamil Hcl	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	19
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	25	suppressed
Clotrimazole	Clotrimazole	24	16
Doxycycline Monohydrate	Doxycycline Monohydrate	24	20
Techlite Pen Needle	Pen Needle, Diabetic	24	suppressed
Benztropine Mesylate	Benztropine Mesylate	23	suppressed
Colchicine	Colchicine	23	suppressed
Loperamide	Loperamide Hcl	23	suppressed
Oxcarbazepine	Oxcarbazepine	23	suppressed
Prednisone	Prednisone	23	suppressed
Gemtesa	Vibegron	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Tresiba Flextouch U-100	Insulin Degludec	21	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	20	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Ammonium Lactate	Ammonium Lactate	18	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	18	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	18	suppressed
Vraylar	Cariprazine Hcl	18	suppressed
Bevespi Aerosphere	Glycopyrrolate/Formoterol Fum	17	suppressed
Prolia	Denosumab	17	13
Temazepam	Temazepam	17	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Cilostazol	Cilostazol	16	suppressed
Flecainide Acetate	Flecainide Acetate	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Atenolol	Atenolol	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Gemfibrozil	Gemfibrozil	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Metolazone	Metolazone	14	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	14	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Cephalexin	Cephalexin	13	12
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Digoxin	Digoxin	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Finasteride	Finasteride	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Multaq	Dronedarone Hcl	12	suppressed
Niacin Er	Niacin	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Dexilant	Dexlansoprazole	11	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Nystop	Nystatin	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Valsartan	Valsartan	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$56.55 · 3 records	Boehringer Ingelheim Pharmaceuticals, Inc.	JARDIANCE	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Boehringer Ingelheim Pharmaceuticals, Inc.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error